Skip to main content
P

Precisionthera

The startup develops immune cell preparations and application technologies specifically designed for cancer patients, enhancing the efficacy of immunotherapy treatments. By focusing on personalized medicine, the company aims to improve patient outcomes and quality of life through targeted therapeutic interventions.

臺北市, 臺灣
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Cancer immunotherapy faces challenges in achieving consistent efficacy and accessibility due to the limitations of current treatment approaches. Personalized medicine strategies are needed to enhance patient outcomes and quality of life through targeted therapeutic interventions.

Solution

Precision Biotech develops immune cell preparations and application technologies designed to improve the effectiveness of cancer immunotherapy. The company focuses on developing both autologous and allogeneic cell therapies, including NK/NKT, DC, and hMSC-based treatments. Precision Biotech operates a GMP-compliant cell preparation facility and collaborates with hospitals and physicians to provide cell therapy products for clinical use under applicable regulations. The company is also developing a platform for NK/NKT cell engineering and has multiple CAR-NK product candidates in preclinical and clinical development.

Target Audience

The primary target audience includes hospitals, physicians, and clinical researchers involved in cancer immunotherapy, as well as patients seeking advanced cell-based treatment options.

Features

  • Development of autologous and allogeneic immune cell therapies (NK/NKT, DC, hMSC)
  • GMP-compliant cell preparation for clinical use
  • Clinical trial programs for PB101 (autologous) and PB103 (allogeneic) cell therapies
  • NK/NKT cell engineering platform
  • CAR-NK product candidates for solid tumors and hematological malignancies
  • Development of exosome-based products
  • Cell therapy process development and analysis services
  • Assistance with clinical trial applications and execution
  • Consulting services for GTP-compliant cell therapy manufacturing
  • Testing services for sterility, mycoplasma, and endotoxins
This profile is AI-generated and may contain inaccuracies.